Bone Biologics Submits Patent Application for Bone Regeneration Technology
Bone Biologics has filed a US patent application for its novel NELL-1 protein, aiming to advance bone regeneration treatments and strengthen its spine fusion therapy portfolio.
NELL-1 Protein | 01/07/2025 | By Mrinmoy Dey | 166
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy